Antibody-mediated sialidase activity in blood serum of patients with multiple myeloma

Journal of Molecular Recognition

Volumn 24, Issue 4, 2011, Pages 576-584

  Bilyy, Rostyslav ^a   Tomin, Andriy ^a   Mahorivska, Iryna ^a   Shalay, Olga ^b   Lohinskyy, Volodymyr ^b   Stoika, Rostyslav ^a   Kit, Yuriy ^a  

^a INSTITUTE OF CELL BIOLOGY   (Ukraine)

^b Hematology Department of the Academy of Medical Sciences of Ukraine   (Ukraine)

Author keywords

abzyme; catalytic antibody; immunoglobulins; multiple myeloma; sialidase activity

Indexed keywords

CATALYTIC ANTIBODY; SIALIDASE;

ADULT; ARTICLE; BLOOD; ENZYMOLOGY; FEMALE; GEL CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTIPLE MYELOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; ANTIBODIES, CATALYTIC; BLOTTING, WESTERN; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEURAMINIDASE;

ARACHIS HYPOGAEA;

EID: 79953789945     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.1071     Document Type: Article

References (64)

1. Anthony RM, Wermeling F, Karlsson MC, Ravetch JV,. 2008a. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc. Natl. Acad. Sci. USA 105 (50): 19571-19578.
2. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV,. 2008b. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320 (5874): 373-376. (Pubitemid 351555659)
3. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA,. 2007. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25: 21-50. (Pubitemid 46697901)
4. Belogurov A, Jr., Kozyr A, Ponomarenko N, Gabibov A,. 2009. Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde. BioEssays. 31 (11): 1161-1171.
5. Bigi A, Morosi L, Pozzi C, Forcella M, Tettamanti G, Venerando B, Monti E, Fusi P,. 2010. Human sialidase NEU4 long and short are extrinsic proteins bound to outer mitochondrial membrane and the endoplasmic reticulum, respectively. Glycobiology 20 (2): 148-157.
6. Bilyy R, Stoika R,. 2007. Search for novel cell surface markers of apoptotic cells. Autoimmunity 40 (4): 249-253. (Pubitemid 46845516)
7. Bilyy R, Nemesh L, Antonyuk V, Kit Y, Valchuk I, Havryluk A, Chopyak V, Stoika R,. 2009. Apoptosis-related changes in plasma membrane glycoconjugates of peripheral blood lymphocytes in rheumatoid arthritis. Autoimmunity 42 (4): 334-336.
8. Bond A, Alavi A, Axford JS, Bourke BE, Bruckner FE, Kerr MA, Maxwell JD, Tweed KJ, Weldon MJ, Youinou P, Hay FC,. 1997. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. J. Autoimmun. 10 (1): 77-85. (Pubitemid 27110310)
9. Chavas LM, Tringali C, Fusi P, Venerando B, Tettamanti G, Kato R, Monti E, Wakatsuki S,. 2005. Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition. J. Biol. Chem. 280 (1): 469-475. (Pubitemid 40165011)
10. Collin M, Shannon O, Bjorck L,. 2008. IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc. Natl. Acad. Sci. USA 105 (11): 4265-4270. (Pubitemid 351754369)
11. Comelli EM, Amado M, Lustig SR, Paulson JC,. 2003. Identification and expression of Neu4, a novel murine sialidase. Gene 321: 155-161. (Pubitemid 37421406)
12. Friboulet A, Izadyar L, Avalle B, Roseto A, Thomas D,. 1994. Abzyme generation using an anti-idiotypic antibody as the "internal image" of an enzyme active site. Appl. Biochem. Biotechnol. 47 (2-3): 229-237; discussion 237-239.
13. Friemel H,. 1991. Immunologische Arbeitsmethoden. Elsevier, München: München.
14. Gabibov AG, Kozyr AV, Kolesnikov AV,. 2000. Disease association and cytotoxic effects of DNA-hydrolyzing autoantibodies. Chem. Immunol. 77: 130-156.
15. Gabibov AG, Ponomarenko NA, Tretyak EB, Paltsev MA, Suchkov SV,. 2006. Catalytic autoantibodies in clinical autoimmunity and modern medicine. Autoimmun. Rev. 5 (5): 324-330. (Pubitemid 43868200)
16. Gololobov GV, Chernova EA, Schourov DV, Smirnov IV, Kudelina IA, Gabibov AG,. 1995. Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. Proc. Natl. Acad. Sci. USA 92 (1): 254-257.
17. Hanson CV, Nishiyama Y, Paul S,. 2005. Catalytic antibodies and their applications. Curr. Opin. Biotechnol. 16 (6): 631-636. (Pubitemid 41654641)
18. Hinek A, Pshezhetsky AV, von IM, Starcher B,. 2006. Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly. J. Biol. Chem. 281 (6): 3698-3710. (Pubitemid 43845988)
19. Inoue S, Kitajima K,. 2006. KDN (deaminated neuraminic acid): dreamful past and exciting future of the newest member of the sialic acid family. Glycoconj. J. 23 (5-6): 277-290. (Pubitemid 44202032)
20. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I, Miyagi T,. 2002. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc. Natl. Acad. Sci. USA 99 (16): 10718-10723.
21. Kaneko Y, Nimmerjahn F, Ravetch JV,. 2006. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313 (5787): 670-673. (Pubitemid 44201145)
22. Kanyshkova TG, Semenov DV, Khlimankov D, Buneva VN, Nevinsky GA,. 1997. DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers. FEBS Lett. 416 (1): 23-26. (Pubitemid 27470793)
23. Kit YY, Starykovych MA, Richter VA, Stoika RS,. 2008. Detection and characterization of IgG- and sIgA-Abzymes capable of hydrolyzing histone H1. Biochemistry (Mosc) 73 (8): 950-956.
24. Kozyr AV, Kolesnikov AV, Iakhnina EI, Astsaturov IA, Varlamova E, Kirillov EV, Gabibov AG,. 1996. DNA-hydrolyzing antibodies in lymphoproliferative disorders. Biull. Eksp. Biol. Med. 121 (2): 204-206.
25. Kozyr AV, Kolesnikov AV, Aleksandrova ES, Sashchenko LP, Gnuchev NV, Favorov PV, Kotelnikov MA, Iakhnina EI, Astsaturov IA, Prokaeva TB, et al,. 1998. Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl. Biochem. Biotechnol. 75 (1): 45-61. (Pubitemid 29168618)
26. Kozyr AV, Sashchenko LP, Kolesnikov AV, Zelenova NA, Khaidukov SV, Ignatova AN, Bobik TV, Gabibov AG, Alekberova ZS, Suchkov SV, et al,. 2002. Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol. Lett. 80 (1): 41-47. (Pubitemid 33096314)
27. Lacroix-Desmazes S, Wootla B, Delignat S, Dasgupta S, Nagaraja V, Kazatchkine MD, Kaveri SV,. 2006. Pathophysiology of catalytic antibodies. Immunol. Lett. 103 (1): 3-7. (Pubitemid 43162939)
28. Laemmli UK,. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (5259): 680-685.
29. Li YT, Yuziuk JA, Li SC, Nematalla A, Hasegawa A, Kimura M, Nakagawa H,. 1994. A novel sialidase capable of cleaving 3-deoxy-D-glycero-D-galacto-2- nonulosonic acid (KDN). Arch. Biochem. Biophys. 310 (1): 243-246. (Pubitemid 24171492)
30. Magorivska I, Bilyy R, Shalay O, Loginsky V, Kit Y, Stoika R,. 2009. Blood serum immunoglobulins of patients with multiple myeloma are capable of hydrolysing histone H1. Exp. Oncol. 31 (2): 97-101.
31. Magorivska I, Bilyy R, Havryluk A, Chop'yak V, Stoika R, Kit Y,. 2010. Anti-histone H1 IgGs from blood serum of systemic lupus erythematosus patients are capable of hydrolyzing histone H1 and myelin basic protein. J. Mol. Recognit. DOI: 10.1002/jmr.1033.
32. Matsuura K, Ohara K, Munakata H, Hifumi E, Uda T,. 2006. Pathogenicity of catalytic antibodies: catalytic activity of Bence Jones proteins from myeloma patients with renal impairment can elicit cytotoxic effects. Biol. Chem. 387 (5): 543-548. (Pubitemid 44071456)
33. Meesmann HM, Fehr E-M, Kierschke S, Herrmann M, Bilyy R, Heyder P, Blank N, Krienke S, Lorenz HM, Schiller M,. 2010. Decrease of sialic acid residues as an eat-me signal on the surface of apoptotic lymphocytes. Journal of Cell Science 123: in press.
34. Miyagi T,. 2008. Aberrant expression of sialidase and cancer progression. Proc. Jpn. Acad. B 84 (10): 407-418.
35. Miyagi T, Wada T, Yamaguchi K, Hata K,. 2004. Sialidase and malignancy: a minireview. Glycoconj. J. 20 (3): 189-198. (Pubitemid 39024047)
36. Miyagi T, Wada T, Yamaguchi K, Shiozaki K, Sato I, Kakugawa Y, Yamanami H, Fujiya T,. 2008a. Human sialidase as a cancer marker. Proteomics 8 (16): 3303-3311.
37. Miyagi T, Wada T, Yamaguchi K,. 2008b. Roles of plasma membrane-associated sialidase NEU3 in human cancers. Biochim. Biophys. Acta. 1780 (3): 532-537. (Pubitemid 351395305)
38. Miyagi T, Wada T, Yamaguchi K, Hata K, Shiozaki K,. 2008c. Plasma membrane-associated sialidase as a crucial regulator of transmembrane signalling. J. Biochem. 144 (3): 279-285.
39. Monti E, Bassi MT, Papini N, Riboni M, Manzoni M, Venerando B, Croci G, Preti A, Ballabio A, Tettamanti G, et al,. 2000. Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem. J. 349 (Pt 1): 343-351. (Pubitemid 30440200)
40. Monti E, Preti A, Venerando B, Borsani G,. 2002. Recent development in mammalian sialidase molecular biology. Neurochem. Res. 27 (7-8): 649-663.
41. Nakano V, Fontes Piazza RM, Avila-Campos MJ,. 2006. A rapid assay of the sialidase activity in species of the Bacteroides fragilis group by using peanut lectin hemagglutination. Anaerobe 12 (5-6): 238-241. (Pubitemid 44666465)
42. Nevinsky GA, Buneva VN,. 2003. Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases. J. Cell. Mol. Med. 7 (3): 265-276. (Pubitemid 37372046)
43. Nevinsky GA, Buneva VN,. 2005. Natural catalytic antibodies-abzymes. In Catalytic Antibodies., Ehud K, (ed.). Wiley-VCH Verlag GmbH & Co.: KGaA, Weinheim, FRG. 505-569 DOI: 10.1002/3527603662.ch19
44. Nimmerjahn F, Anthony RM, Ravetch JV,. 2007. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc. Natl. Acad. Sci. USA 104 (20): 8433-8437. (Pubitemid 47175505)
45. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K, et al,. 1985. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316 (6027): 452-457. (Pubitemid 16238456)
46. Parekh R, Isenberg D, Rook G, Roitt I, Dwek R, Rademacher T,. 1989. A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J. Autoimmun. 2 (2): 101-114.
47. Paul S, Volle DJ, Beach CM, Johnson DR, Powell MJ, Massey RJ,. 1989. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244 (4909): 1158-1162. (Pubitemid 19170484)
48. Paul S, Li L, Kalaga R, Wilkins-Stevens P, Stevens FJ, Solomon A,. 1995. Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment. J. Biol. Chem. 270 (25): 15257-15261.
49. Planque S, Nishiyama Y, Taguchi H, Salas M, Hanson C, Paul S,. 2008. Catalytic antibodies to HIV: physiological role and potential clinical utility. Autoimmun. Rev. 7 (6): 473-479.
50. Pollack SJ, Jacobs JW, Schultz PG,. 1986. Selective chemical catalysis by an antibody. Science 234 (4783): 1570-1573. (Pubitemid 17125282)
51. Rook GA, Steele J, Brealey R, Whyte A, Isenberg D, Sumar N, Nelson JL, Bodman KB, Young A, Roitt IM, et al,. 1991. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J. Autoimmun. 4 (5): 779-794.
52. Samollow PB, VandeBerg JL, Kunz HW, Gill TJ III., 1985. Analysis of neuraminidase isozyme phenotypes in mammalian tissues: an electrophoretic approach. Biochem. Biophys. Res. Commun. 126 (3): 1182-1188. (Pubitemid 15148987)
53. Sashchenko LP, Khaidukov SV, Kozyr AV, Luk'yanova TI, Gabibov AG, Suchkov SV, Bobik TV, Alekberova ZS, Gnuchev NV,. 2001. Caspase-dependent cytotoxicity of anti-DNA autoantibodies. Dokl. Biochem. Biophys. 380: 313-315.
54. Saveliev AN, Ivanen DR, Kulminskaya AA, Ershova NA, Kanyshkova TG, Buneva VN, Mogelnitskii AS, Doronin BM, Favorova OO, Nevinsky GA, et al,. 2003. Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol. Lett. 86 (3): 291-297. (Pubitemid 36428690)
55. Sawada M, Moriya S, Saito S, Shineha R, Satomi S, Yamori T, Tsuruo T, Kannagi R, Miyagi T,. 2002. Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int. J. Cancer 97 (2): 180-185. (Pubitemid 34019953)
56. Scanlan CN, Burton DR, Dwek RA,. 2008. Making autoantibodies safe. Proc. Natl. Acad. Sci. USA 105 (11): 4081-4082. (Pubitemid 351754337)
57. Seyrantepe V, Landry K, Trudel S, Hassan JA, Morales CR, Pshezhetsky AV,. 2004. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells. J. Biol. Chem. 279 (35): 37021-37029. (Pubitemid 39129052)
58. Sinohara H, Matsuura K,. 2000. Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma? Appl. Biochem. Biotechnol. 83 (1-3): 85-92; discussion 93-4, 145-53.
59. Sun M, Gao QS, Kirnarskiy L, Rees A, Paul S,. 1997. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain. J. Mol. Biol. 271 (3): 374-385. (Pubitemid 27348505)
60. Taguchi H, Planque S, Nishiyama Y, Szabo P, Weksler ME, Friedland RP, Paul S,. 2008. Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease. Autoimmun. Rev. 7 (5): 391-397.
61. Tramontano A, Janda KD, Lerner RA,. 1986. Catalytic antibodies. Science 234 (4783): 1566-1570. (Pubitemid 17125281)
62. Warner TG, O'Brien JS,. 1979. Synthesis of 2'-(4-methylumbelliferyl)- alpha-D-N-acetylneuraminic acid and detection of skin fibroblast neuraminidase in normal humans and in sialidosis. Biochemistry 18 (13): 2783-2787. (Pubitemid 9234809)
63. Yamaguchi K, Hata K, Koseki K, Shiozaki K, Akita H, Wada T, Moriya S, Miyagi T,. 2005. Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem. J. 390 (Pt 1): 85-93. (Pubitemid 41192234)
64. Yamanami H, Shiozaki K, Wada T, Yamaguchi K, Uemura T, Kakugawa Y, Hujiya T, Miyagi T,. 2007. Down-regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers. Cancer Sci. 98 (3): 299-307. (Pubitemid 46195598)